Internal Medicine, Hematology & Oncology · Rochester, NY
NPI
1932302932
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
601 Elmwood Ave, Box Med
Rochester, NY, 14642
Phone (585) 275-5823
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
173 services
Medicare patients, 2024
144
Average age 66
Drug cost, 2024
$1.3M
405 prescriptions
Company payments, 2025
$300
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank Akwaa was code 99215 (office e&m - established), 81 times for 76 patients. In total Frank Akwaa billed 173 services in 11 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 81 | 76 | $94.17 | $7,628 |
| 99214 Office E&M - Established | Office | 28 | 28 | $63.71 | $1,784 |
| 99451 E&M - Miscellaneous | Office | 20 | 20 | $23.92 | $478 |
| 99222 Hospital E&M - Initial | Facility | 19 | 18 | $97.74 | $1,857 |
By year: 2022 $21K for 302 services; 2023 $19K for 243 services; 2024 $13K for 173 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frank Akwaa prescribed most often to Medicare patients was Eliquis (Apixaban), with 73 prescriptions and refills. In total Frank Akwaa wrote 405 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 73 | 103 | 26 | $58K |
| Hydroxyurea Generic | 62 | 105 | 18 | $1,052 |
| Xarelto Rivaroxaban | 60 | 94 | 17 | $51K |
| Deferasirox Generic | 51 | 51 | Under 11 | $111K |
| Prednisone Generic | 18 | 22 | Under 11 | $42.96 |
| Promacta Eltrombopag Olamine | 17 | 17 | Under 11 | $135K |
| Oxbryta Voxelotor | 15 | 17 | Under 11 | $202K |
| Jakafi Ruxolitinib Phosphate | 15 | 15 | Under 11 | $260K |
| Lenalidomide Generic | 13 | 13 | Under 11 | $194K |
| Imbruvica Ibrutinib | 13 | 13 | Under 11 | $188K |
Brand drugs: 219 claims; generic drugs: 186 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank Akwaa $300 ($300 in general payments such as food, travel and fees) from 1 company. The largest payer was Sekisui Diagnostics LLC with $300.
| Company | Payments | Amount |
|---|---|---|
| Sekisui Diagnostics LLC | 1 | $300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.